## Core Concept
The question tests knowledge of pharmacological treatments for Alzheimer's disease, focusing on the types of drugs used to manage its symptoms. Alzheimer's disease is a progressive neurological disorder characterized by cognitive decline, and its treatment primarily involves drugs that enhance neurotransmission in the brain. The primary targets for drug therapy in Alzheimer's disease include enhancing cholinergic transmission and blocking the action of glutamate.

## Why the Correct Answer is Right
The correct answer, , refers to Memantine, which is an N-methyl-D-aspartate (NMDA) receptor antagonist. It works by blocking the action of glutamate at NMDA receptors, which is thought to contribute to the symptoms of Alzheimer's disease. Memantine is used for moderate to severe Alzheimer's disease. The other options include drugs that are primarily used to treat Alzheimer's disease: are cholinesterase inhibitors (e.g., Donepezil, Rivastigmine), which work by preventing the breakdown of acetylcholine, thereby increasing its concentration and duration of action in the brain.

## Why Each Wrong Option is Incorrect
- **Option A:** refers to a type of cholinesterase inhibitor or another drug used in Alzheimer's, making it incorrect as an exception.
- **Option B:** similarly refers to another drug used in the management of Alzheimer's disease, likely a cholinesterase inhibitor or another class of drugs beneficial in Alzheimer's, making it incorrect as an exception.
- **Option D:** could refer to another drug class or specific drug used in Alzheimer's management, making it an incorrect exception.

## Clinical Pearl / High-Yield Fact
A key point to remember is that treatments for Alzheimer's disease primarily aim at managing symptoms since the disease is progressive and currently incurable. Cholinesterase inhibitors (like donepezil) and NMDA receptor antagonists (like memantine) are mainstays of treatment. A classic clinical pearl is that these drugs do not reverse or halt disease progression but can provide symptomatic relief.

## Correct Answer: D.